Sung-Hyun Kim, Dong-Wook Kim. Comment on “Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors”. Haematologica 2015;100(3):e120-e121; https://doi.org/10.3324/haematol.2014.123232.